Attorney Robert Rush joins Joe in Breckenridge to talk about challenging DEA scheduling decisions, from the 2024 DOI and DOC hearing to the emergency scheduling of 7-OH compounds and SR-17018. They also look at what FDA approval of MDMA and psilocybin could mean if only the pharmaceutical versions get rescheduled.